Levine, Joshua A.
Oleaga, Carlota
Eren, Mesut
Amaral, Ansel P.
Shang, Meng
Lux, Elizabeth
Khan, Sadiya S.
Shah, Sanjiv J.
Omura, Yasuhiro
Pamir, Nathalie
Hay, Joshua
Barish, Grant
Miyata, Toshio
Tavori, Hagai
Fazio, Sergio
Vaughan, Douglas E.
Funding for this research was provided by:
Endocrine Fellows Foundation
National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007169)
American Heart Association (15CVGPSD27260148)
National Institutes of Health (RO1HL51387, RO1HL136373, RO1HL132985, RO1HL142761)
Irving S. Cutter Endowment
Article History
Received: 26 June 2020
Accepted: 10 December 2020
First Online: 11 January 2021
Competing interests
: TM is an employee of RenaScience. JAL, TM, and DEV hold provisional patent number 47460-64 (NU2019-041-01). JAL is an employee and holds equity at Eli Lilly and Company. CO, ME, APA, MS, EL, SSK, SJS, YO, NP, JH, GB, HT, and SF report not competing interests.